abstract |
The present disclosure provides a composition containing a bioactive fraction derived from concentrated platelets, a method for producing the bioactive fraction, and a culture medium supplemented with the bioactive fraction. The preferred bioactive fraction has a relatively low fibrinogen concentration while retaining the native growth factor in a beneficial amount and ratio. [Selection] Figure 2 |